Cancer ends here
Parker Institute for Cancer Immunotherapy (parkerici.org) scores 77 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Non-profit brands, in the 59th percentile of 20428 Healthcare brands.
Parker Institute for Cancer Immunotherapy is a nonprofit organization founded in 2016 and headquartered in San Francisco, United States. It focuses on accelerating the discovery, development, and delivery of breakthrough cancer immunotherapy treatments by uniting leading researchers and institutions in a collaborative model that bridges academia and industry. The organization aims to move faster than any single institution could alone, serving cancer researchers, clinicians, patients, and donors interested in advancing cancer cures.
| Brand Name | Parker Institute for Cancer Immunotherapy |
|---|---|
| Domain | parkerici.org |
| Industry | Healthcare, Non-profit |
| Founded | 2016 |
| Headquarters | San Francisco, United States |
| Main Competitors | Cancer Research Institute (82/100), Stand Up To Cancer, American Association for Cancer Research (85/100), Mark Foundation for Cancer Research, Damon Runyon Cancer Research Foundation, V Foundation for Cancer Research |
Moz Domain Authority 52/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,514,197 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Parker is a nonprofit rewiring how breakthrough cancer immunotherapy treatments are discovered, developed and delivered to patients." (Meta description: 17 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Next.js, Vercel.
Social footprint: verified profiles on LinkedIn, X (Twitter), Facebook, Instagram, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Parker Institute for Cancer Immunotherapy?", Claude could identify the brand as of October 2026. The Parker Institute for Cancer Immunotherapy is a nonprofit founded by tech entrepreneur Sean Parker in 2016 that funds and coordinates collaborative cancer immunotherapy research across leading academic institutions and researchers. It aims to accelerate the development of immu Best known for Funding and coordinating collaborative cancer immunotherapy research across major academic cancer centers, founded with a $250 million gift from Sean Parker.
When asked "Best brands similar to Parker Institute for Cancer Immunotherapy?", Claude would recommend Parker Institute for Cancer Immunotherapy as of October 2026. It's a prominent and well-regarded funder and collaborator in cancer immunotherapy research, so it would naturally come up in discussions of leading organizations advancing immuno-oncology.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Parker Institute for Cancer Immunotherapy's main competitors in Healthcare: Cancer Research Institute (82/100), American Association for Cancer Research (85/100).
Sources: Brand Analyzer scan
Parker Institute for Cancer Immunotherapy has limited AI-search visibility, scoring 32/100 on Brand Analyzer's AI visibility composite (visibility 23, trust 29, recommendation 53). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Parker Institute for Cancer Immunotherapy official site
Parker Institute for Cancer Immunotherapy was founded in 2016. Parker Institute for Cancer Immunotherapy operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Parker Institute for Cancer Immunotherapy scores 53/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Parker Institute for Cancer Immunotherapy official site
Parker Institute for Cancer Immunotherapy is a nonprofit organization, founded in 2016 and based in San Francisco, dedicated to advancing cancer immunotherapy research. It operates as a collaborative network that connects researchers and institutions to speed the discovery, development, and delivery of new immunotherapy treatments for cancer.
Sources: Parker Institute for Cancer Immunotherapy official site
Parker Institute for Cancer Immunotherapy can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Parker Institute for Cancer Immunotherapy official site
Parker Institute for Cancer Immunotherapy's work is used and engaged with by cancer researchers and clinicians who participate in its collaborative research network, patients seeking access to emerging immunotherapy treatments, and donors who support its mission to advance cancer cures.
Sources: Parker Institute for Cancer Immunotherapy official site
Parker Institute for Cancer Immunotherapy scores 32/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Parker Institute for Cancer Immunotherapy has a weak AI-visibility profile at 32/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (53/100) and its weakest is visibility (23/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,514,197 (Tranco) and a Moz Domain Authority of 52/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, thin schema.org structured data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Parker Institute for Cancer Immunotherapy from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Parker Institute for Cancer Immunotherapy: Parent Project Muscular Dystrophy (PPMD) (77/100), Parachute Health (77/100), Parker Laboratories (77/100), PasseportSanté (77/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.